Article

Biogen has selected the cloud-based technology of Medidata to support its forthcoming clinical trials. Biogen will increase the adoption of …

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in Digital Healthcare


Digital Healthcare

Telemedicine Technology Opening a Safer Option to Medical Abortions

Earlier forms of telemedicine via telephone and radio has advanced into the age of online telemedicine where patients can have ...

Digital Healthcare

IIT Kharagpur Researchers Develop AmbuSens for Patient Health Monitoring in Ambulance

In Bangalore, a two-year-old girl was being taken to the hospital that was 15 km away from her; it might ...

Digital Healthcare

Samsung Must Need Mobile App for Diabetes Management

The use of smartphones, tablets and other mobile platforms have increased in leaps and bounds in last six to seven ...

Digital Healthcare

FDA Approves Sanofi‘s Diabetes Management Smartphone App

Rising incidence of diabetes around the world is being tactically coped by various novel medications and digital healthcare technologies and ...

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Highlights Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our ...

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply